Cargando…
P64. T cell re-direction against Glypican-3 for immunotherapy of hepatocellular carcinoma
Autores principales: | Dargel, C, Bassani-Sternberg, M, Krebs, K, Wilde, S, Schendel, D, Busch, DH, Mann, M, Protzer, U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072158/ http://dx.doi.org/10.1186/2051-1426-2-S2-P38 |
Ejemplares similares
-
P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014) -
P32. High resolution mass spectrometry reveals the depth and diversity of HLA-I peptidomes
por: Bassani-Sternberg, M, et al.
Publicado: (2014) -
Development of anti-GPC-1 (glypican-1)-CAR-T cells for adoptive T cell immunotherapies for squamous cell carcinoma
por: Yaguchi, Tomonori, et al.
Publicado: (2015) -
Cancer immunotherapy‐targeted glypican‐3 or neoantigens
por: Shimizu, Yasuhiro, et al.
Publicado: (2018) -
Next-Generation Cancer Immunotherapy Targeting Glypican-3
por: Shimizu, Yasuhiro, et al.
Publicado: (2019)